20/20 Biolabs, Inc. (AIDX)
NASDAQ: AIDX · Real-Time Price · USD
0.4220
+0.0130 (3.18%)
Sep 29, 2026, 1:49 PM EDT - Market open
20/20 Biolabs Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4.55 | 1.03 | 1.78 | 4.09 | 8.81 | 3.35 |
Cash & Short-Term Investments | 4.55 | 1.03 | 1.78 | 4.09 | 8.81 | 3.35 |
Cash Growth | 343.98% | -42.49% | -56.38% | -53.57% | 162.56% | 2.47% |
Receivables | 0.29 | 0.2 | 0.14 | 0.07 | 0.76 | 4.22 |
Inventory | 0.11 | 0.12 | 0.05 | 0.06 | 0.09 | 0.25 |
Prepaid Expenses | 0.13 | 0.13 | 0.07 | 0.08 | 0.07 | 0.13 |
Total Current Assets | 5.08 | 1.47 | 2.03 | 4.3 | 9.73 | 7.94 |
Property, Plant & Equipment | 0.55 | 0.66 | 0.89 | 1.18 | 1.67 | 1.68 |
Other Intangible Assets | 0.47 | 0.47 | 0.5 | 0.53 | 0.52 | 0.58 |
Long-Term Accounts Receivable | - | - | - | - | 0 | 0 |
Long-Term Deferred Charges | - | 1.51 | - | 0.15 | - | - |
Other Long-Term Assets | 0.02 | 0.02 | 0.16 | 0.21 | 0.29 | 0.07 |
Total Assets | 6.12 | 4.14 | 3.58 | 6.37 | 12.22 | 10.27 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.03 | 0.87 | 0.37 | 0.36 | 0.46 | 0.83 |
Accrued Expenses | 0.86 | 0.79 | 0.35 | 0.23 | 0.65 | 1.12 |
Current Portion of Long-Term Debt | - | 0.07 | - | - | - | - |
Current Portion of Leases | 0.19 | 0.18 | 0.17 | 0.16 | 0.2 | 0.15 |
Current Unearned Revenue | 0.47 | 0.41 | 0.47 | 0.25 | 0.32 | 0.15 |
Other Current Liabilities | - | 0.14 | - | - | - | - |
Total Current Liabilities | 2.55 | 2.46 | 1.36 | 1.01 | 1.63 | 2.25 |
Long-Term Debt | - | 0.62 | - | 0.23 | 0.21 | - |
Long-Term Leases | 0.38 | 0.49 | 0.67 | 0.84 | 1 | 1.13 |
Long-Term Unearned Revenue | 0.03 | 0.04 | 0.05 | - | - | - |
Other Long-Term Liabilities | - | 0.54 | - | - | - | - |
Total Liabilities | 2.96 | 4.16 | 2.08 | 2.08 | 2.84 | 3.38 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.12 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Additional Paid-In Capital | 38.43 | 33.13 | 30.95 | 28.15 | 26.85 | 26.55 |
Retained Earnings | -36.93 | -33.25 | -29.51 | -23.96 | -17.57 | -19.75 |
Comprehensive Income & Other | - | - | -0.03 | - | - | - |
Total Common Equity | 1.62 | -0.07 | 1.46 | 4.24 | 9.33 | 6.84 |
Shareholders' Equity | 3.16 | -0.02 | 1.51 | 4.29 | 9.37 | 6.89 |
Total Liabilities & Equity | 6.12 | 4.14 | 3.58 | 6.37 | 12.22 | 10.27 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.57 | 1.36 | 0.84 | 1.23 | 1.41 | 1.27 |
Net Cash (Debt) | 3.97 | -0.33 | 0.94 | 2.86 | 7.4 | 2.08 |
Net Cash Growth | 1895.25% | - | -66.94% | -61.38% | 255.53% | -36.44% |
Net Cash Per Share | 0.56 | -0.07 | 0.20 | 0.60 | 0.78 | 0.22 |
Filing Date Shares Outstanding | 12.77 | 10.44 | 4.82 | 4.77 | 4.76 | 4.73 |
Total Common Shares Outstanding | 12.25 | 5.44 | 4.82 | 4.77 | 4.76 | 4.73 |
Working Capital | 2.52 | -0.99 | 0.68 | 3.29 | 8.1 | 5.69 |
Book Value Per Share | 0.13 | -0.01 | 0.30 | 0.89 | 1.96 | 1.45 |
Tangible Book Value | 1.15 | -0.54 | 0.96 | 3.71 | 8.81 | 6.26 |
Tangible Book Value Per Share | 0.09 | -0.10 | 0.20 | 0.78 | 1.85 | 1.32 |
Machinery | 0.53 | 0.57 | 0.57 | 0.71 | 1.15 | 1.06 |
Leasehold Improvements | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |